Acute Wound Dehiscence

1. Clinical Overview

Summary

Wound dehiscence is the partial or complete separation of the layers of a surgical wound following closure. It represents a spectrum from superficial skin separation to complete fascial disruption with evisceration (protrusion of intra-abdominal contents). This serious postoperative complication occurs in 0.5-3% of all abdominal surgeries but carries significant morbidity, with mortality rates of 10-45% when evisceration occurs. [1,2]

The condition is differentiated by depth: superficial dehiscence involves skin and subcutaneous tissue only, while deep/complete dehiscence involves fascial disruption. Evisceration represents the most severe form, where intra-abdominal contents (typically omentum or bowel) protrude through the fascial defect. [3]

Peak incidence occurs 5-10 days postoperatively, often heralded by a characteristic "salmon-colored" serosanguinous discharge from the wound. [4] Risk stratification models identify diabetes mellitus (OR 4.9), postoperative ileus (OR 8.1), chronic obstructive pulmonary disease (OR 2.6), obesity (BMI > 30), and emergency surgery as major independent predictors. [5,6]

Management is stratified by severity: superficial dehiscence may be managed with wound care and delayed closure, while fascial dehiscence with evisceration is a surgical emergency requiring urgent operative repair within 6-12 hours. Negative pressure wound therapy (NPWT) has emerged as both a preventive strategy in high-risk patients and a therapeutic adjunct in managing established dehiscence. [7,8]

Key Facts

• Definition: Separation or opening of surgical wound layers after closure
• Incidence: 0.5-3% of all abdominal surgeries; up to 10% in emergency laparotomy [1,9]
• Mortality: 10-45% when evisceration occurs [2,3]
• Peak timing: 5-10 days postoperatively (70% of cases) [4]
• Critical feature: "Salmon-colored" serosanguinous discharge is pathognomonic herald sign
• Key investigation: Clinical diagnosis; CT abdomen for uncertain fascial integrity
• First-line treatment:
  • "Superficial: Conservative wound management ± delayed closure"
  • "Complete/evisceration: Emergency surgical repair"

Clinical Pearls

"Pink fluid means fascial disruption until proven otherwise" — Serosanguinous ("salmon-colored") discharge from a recent laparotomy wound is pathognomonic for fascial dehiscence and mandates immediate wound exploration. [4]

"The patient who feels a 'pop' needs urgent assessment" — Patients often describe a sudden "tearing" or "giving way" sensation, frequently during coughing or straining, which precedes overt evisceration by hours. [10]

"Evisceration is a 'cover and theatre' emergency" — Exposed viscera should be covered with warm, saline-soaked sterile dressings, the patient kept nil-by-mouth, and emergency theatre arranged within 6 hours. Never attempt to reduce eviscerated organs at the bedside. [3,11]

"High-risk patients benefit from prophylactic NPWT" — Evidence supports incisional NPWT in obese patients, those with diabetes, emergency surgery, and contaminated/dirty wounds to reduce dehiscence rates by 30-50%. Cochrane review of 62 RCTs (13,340 patients) demonstrates significant reduction in surgical site infection (RR 0.64) and dehiscence (RR 0.69). [7,8]

"Small-bite continuous closure reduces dehiscence by 40%" — The STITCH trial demonstrated that small-bite (5mm bites, 5mm intervals) continuous slowly-absorbable suture reduces incisional hernia and dehiscence compared to large-bite technique. [12]

Why This Matters Clinically

Wound dehiscence represents a catastrophic failure of surgical wound healing with profound clinical implications:

Immediate threat: Evisceration exposes sterile intra-abdominal contents to external contamination, creating risk of peritonitis, septic shock, and bowel injury. Mortality approaches 45% in elderly patients. [2,3]

Long-term morbidity: Even successfully repaired dehiscence carries 20-30% risk of subsequent incisional hernia, prolonged hospital stay (mean additional 10 days), and increased healthcare costs (average £14,000 additional cost per case). [13]

Prevention paradigm: Modern evidence supports bundle approaches including glycemic control, nutritional optimization, prophylactic NPWT in high-risk patients, and standardized fascial closure techniques (small-bite continuous suturing) to reduce incidence. [7,12,14]

Exam relevance: Frequently tested in MRCS/FRCS viva and clinical scenarios. Candidates must demonstrate systematic risk assessment, recognition of herald signs, differentiation between superficial and complete dehiscence, and emergency management protocols.

---

2. Epidemiology

Incidence & Prevalence

Overall Incidence:

• All abdominal surgeries: 0.5-3% [1]
• Emergency midline laparotomy: 5-10% [9]
• Colorectal surgery: 2-4% [15]
• Radical cystectomy: 5-8% [5]
• Contaminated/dirty wounds: up to 15% [16]

Evisceration specifically:

• Complete evisceration: 0.3-1% of all laparotomies [3]
• 15-20% of all wound dehiscences progress to evisceration [2]
• Trauma-related evisceration (stab wounds): 80% positive laparotomy rate; low mortality when managed urgently [33]

Temporal trends:

• Incidence declining with modern techniques (small-bite closure, prophylactic NPWT)
• Emergency surgery rates remain stable at 5-10% [9,17]

Demographics

Risk Factors

Non-Modifiable:

Modifiable - Patient Factors:

Modifiable - Operative Factors:

Modifiable - Postoperative Factors:

Risk Stratification Models

van Ramshorst Prediction Model (validated, AUC 0.78): [6]

Score calculated from:

• Age > 75 years (1 point)
• COPD (1 point)
• Ascites (1 point)
• Jaundice (1 point)
• Anemia (1 point)
• Emergency surgery (1 point)
• Sepsis (1 point)
• Wound contamination Class III-IV (1 point)

Interpretation:

• 0-2 points: Low risk (less than 2%)
• 3-4 points: Moderate risk (5-10%)
• ≥5 points: High risk (> 15%) - consider prophylactic interventions

ACS-NSQIP Modified Model includes additional factors:

• Diabetes mellitus
• Obesity (BMI > 30)
• Steroid use
• ASA class ≥3

---

3. Aetiology & Pathophysiology

Classification Systems

By Depth (Southampton Wound Assessment Scale modified):

By Timing:

By Mechanism (Carlson Classification):

1. Mechanical failure: Suture breakage, knot failure, tissue pullthrough
2. Biological failure: Impaired healing (infection, malnutrition, ischemia)
3. Combined: Most common - biological factors precipitate mechanical failure

Molecular Pathophysiology

Normal Fascial Healing Timeline:

Days 0-4 (Hemostasis/Inflammation):

• Platelet aggregation, fibrin clot formation
• Neutrophil infiltration (peak 24-48 hours)
• Macrophage recruitment
• Tensile strength: 0-5% of original (relies entirely on sutures)

Days 5-21 (Proliferation):

• Fibroblast proliferation and migration
• Collagen type III deposition (immature collagen)
• Angiogenesis
• Granulation tissue formation
• Tensile strength: Gradually increases to 20% by day 21
• Critical period: Days 5-10 when inflammatory phase wanes but collagen maturation incomplete - highest dehiscence risk

Days 21-365+ (Remodeling):

• Collagen type I replaces type III (mature, cross-linked collagen)
• Collagen realignment along tension lines
• Scar maturation
• Tensile strength: Reaches 70-80% of original by 3 months; never exceeds 80%

Pathophysiology of Dehiscence:

Imbalance of Synthesis vs. Degradation:

Normal healing requires:

• Matrix metalloproteinases (MMPs) for tissue remodeling
• Tissue inhibitors of metalloproteinases (TIMPs) to prevent excessive degradation
• Balance: MMP/TIMP ratio ~1.0

In dehiscence:

• Infection: Bacterial proteases + excessive MMP activity (MMP-8, MMP-9)
• Inflammation: IL-1β, TNF-α upregulate MMPs
• Result: MMP/TIMP ratio > 2.0 → collagen degradation exceeds synthesis → mechanical failure [25]

Diabetes-Specific Mechanisms:

• Advanced glycation end products (AGEs) impair fibroblast function
• Microvascular disease reduces tissue oxygen delivery
• Impaired neutrophil chemotaxis and phagocytosis
• Reduced growth factor signaling (PDGF, TGF-β) [20]

Mechanical Factors:

Intra-abdominal Pressure (IAP):

• Normal: 5-7 mmHg
• Coughing/straining: spikes to 100-200 mmHg
• Postoperative ileus: sustained 15-25 mmHg
• Critical threshold: IAP > 12 mmHg correlates with increased dehiscence [26]

Suture-to-Wound Length Ratio (SL:WL):

• Optimal: ≥4:1 (suture length should be 4x wound length)
• Achieved by: small bites (5mm tissue, 5mm intervals), running technique
• less than 4:1 ratio increases risk by OR 3.1 [23]

"Small-bite" Technique (STITCH trial): [12]

• 5mm tissue bites, 5mm intervals
• Continuous slowly-absorbable monofilament
• Reduces incisional hernia by 40% (13.5% vs 21.2%, pless than 0.001)
• Mechanism: Better tissue perfusion, optimal SL:WL ratio, reduced ischemia

Microbiology of Infected Dehiscence

Common Organisms:

Polymicrobial infections (60% of cases) associated with:

• Higher dehiscence rates
• Increased evisceration risk
• Delayed healing

---

4. Clinical Presentation

Symptoms: The Patient's Story

Herald Signs (24-48 hours before overt dehiscence):

Superficial Dehiscence:

• Wound drainage (serous, serosanguinous, or purulent)
• Wound edges separated but no deep disruption
• Minimal pain (unless infected)
• No systemic features

Deep/Fascial Dehiscence:

• Salmon-colored fluid (peritoneal fluid mixed with blood) - pathognomonic
• Sensation of "giving way" or "tearing"
• May palpate fascial defect beneath skin
• Visible bowel loops beneath skin (pre-evisceration)

Complete Evisceration:

• Visible protruding viscera (omentum 60%, small bowel 30%, colon 10%)
• Often sudden event during coughing/vomiting/straining
• Severe pain initially, then may reduce (concerning - suggests ischemia)
• Distress, anxiety

Associated Symptoms:

• Fever (if infected): 30-40% of cases
• Abdominal distension (ileus): 50-60%
• Persistent cough (precipitating factor): 40%
• Severe constipation/straining: 20-30%

Signs: What You See

Vital Signs:

General Inspection:

Patient Appearance:

• Superficial: Usually well, ambulatory
• Deep/evisceration: Distressed, anxious, may be immobile due to fear of further disruption
• Septic: Toxic appearance, confusion (elderly), hypotension

Abdominal Examination (ABCDE Approach in Emergency):

Exposure:

• Position patient supine
• Remove dressings carefully (support wound if evisceration suspected)
• Full abdominal exposure from xiphoid to pubis

Inspection:

Palpation (Gentle - do NOT reduce eviscerated organs):

• Fascial edges: Can you palpate fascial defect?
• Defect size: Estimate in cm (dictates operative approach)
• Tenderness: Localized vs. diffuse (peritonitis?)
• Abdominal distension: Ileus common (50-60%)
• Abdominal rigidity/guarding: Suggests peritonitis

Percussion:

• Tympany if ileus
• Shifting dullness if ascites

Auscultation:

• Absent/reduced bowel sounds if ileus (common)
• Normal bowel sounds don't exclude dehiscence

Rectal/Vaginal Examination (if indicated):

• Assess for pelvic collections
• Anastomotic leak (if colorectal surgery)

Specific Examination Findings by Type

Superficial Dehiscence:

• Skin separation 1-3 cm
• Subcutaneous tissue visible
• Key finding: Fascia intact on palpation with sterile probe (if available) or gentle examination
• Usually minimal systemic upset

Deep Fascial Dehiscence (Without Evisceration):

• Skin may be partially or completely separated
• Fascial edges palpable as distinct "ridges" within wound
• Key finding: Fascial defect ≥1 cm
• May see peritoneum bulging (intact but visible)
• Pink serosanguinous fluid drainage

Complete Evisceration:

• Omentum (60%): Yellow adipose tissue, relatively benign
• Small bowel (30%): Pink, peristaltic, HIGH RISK of injury/ischemia
• Colon (10%): Darker, haustra visible, VERY HIGH RISK of contamination if perforated
• Assessment: Document organ involved, viability (color, perfusion), contamination

Red Flags - Immediate Escalation Required

[!CAUTION] Red Flags — Surgical Emergency:

• Visible viscera (evisceration) — Cover with warm saline-soaked gauze, NPO, urgent theatre (less than 6 hours)
• "Salmon-colored" serosanguinous fluid — Herald sign of fascial dehiscence, urgent exploration required
• Palpable fascial defect > 2 cm — High risk of evisceration, urgent surgical consultation
• Signs of peritonitis (rigidity, rebound, guarding) — Suggests visceral injury or contamination
• Hemodynamic instability (shock) — Sepsis or hemorrhage, immediate resuscitation + surgery
• Bowel ischemia concerns (dusky/dark eviscerated bowel) — Urgent surgical repair within 2-3 hours
• Deteriorating conscious level (septic encephalopathy) — Intra-abdominal sepsis, urgent source control

---

5. Investigations

Bedside/Immediate Assessment

1. Clinical Diagnosis (Primary - 95% of cases)

Wound dehiscence is a clinical diagnosis. Most cases do not require imaging.

Clinical criteria:

• Recent abdominal surgery (typically 5-10 days)
• Wound separation visible or palpable
• ± Serosanguinous discharge
• ± Herald signs

Wound Exploration (Bedside):

• Indications: Suspected fascial dehiscence, uncertain depth
• Technique: Sterile gloves, gentle probing with sterile swab/probe
• Assessment: Fascial integrity - can you pass probe/finger beneath fascia into peritoneal cavity?
• Caution: Do NOT explore deeply if evisceration present - risk of iatrogenic visceral injury

2. Wound Swab (If Infection Suspected)

• When: Purulent discharge, erythema, fever
• How: Deep tissue swab (not superficial skin)
• Purpose: Microbiology for targeted antibiotics
• Typical organisms: E. coli, S. aureus, Enterococcus, anaerobes

Laboratory Investigations

Imaging

CT Abdomen/Pelvis with IV Contrast:

Indications:

• Uncertain fascial integrity (skin intact but suspected deep dehiscence)
• Suspected intra-abdominal complication (abscess, anastomotic leak, hemorrhage)
• Preoperative planning for complex cases (extensive contamination, prior mesh)
• NOT routinely needed for obvious clinical dehiscence/evisceration

Findings:

Ultrasound (Point-of-Care):

• Limited role in wound dehiscence assessment
• May identify subcutaneous fluid collections
• Cannot reliably assess fascial integrity

Plain X-ray (Abdominal):

• Not useful for diagnosing dehiscence itself
• May show:
  • Ileus (dilated bowel loops)
  • Free intraperitoneal air (if recent surgery, expected; if remote, suggests perforation)
  • Radio-opaque surgical materials (e.g., swabs - if concern for retained foreign body)

Diagnostic Pathway

SUSPECTED WOUND DEHISCENCE
(Recent surgery + wound concerns)
           ↓
┌──────────────────────────────────────┐
│  CLINICAL EXAMINATION                │
│  • Vital signs                       │
│  • Wound inspection                  │
│  • Abdominal examination             │
└──────────────────────────────────────┘
           ↓
    ┌─────────────────┐
    │  Is diagnosis   │
    │     clear?      │
    └─────────────────┘
           ↓
    YES ↙     ↘ NO/UNCERTAIN
       ↓              ↓
┌──────────────┐  ┌────────────────────┐
│ OBVIOUS      │  │ Skin intact OR     │
│ DEHISCENCE   │  │ depth uncertain    │
│              │  │                    │
│ • Visible    │  │ Consider:          │
│   separation │  │ • Bedside wound    │
│ • Palpable   │  │   exploration      │
│   defect     │  │ • CT abdomen/pelvis│
│ • Evisceration│ │                    │
└──────────────┘  └────────────────────┘
       ↓                    ↓
┌──────────────────────────────────────┐
│  LABORATORY TESTS (all cases)        │
│  • FBC, CRP (infection screen)       │
│  • U&E, albumin (risk factors)       │
│  • Glucose (optimize control)        │
│  • Wound swab (if purulent)          │
│  • Blood cultures (if septic)        │
└──────────────────────────────────────┘
       ↓
┌──────────────────────────────────────┐
│  CLASSIFICATION                      │
│  • Superficial (skin/subcut only)    │
│  • Deep (fascial, no evisceration)   │
│  • Complete (evisceration)           │
└──────────────────────────────────────┘
       ↓
   MANAGEMENT PATHWAY

---

6. Management

Emergency Management - First Hour

Evisceration Protocol (Surgical Emergency):

Immediate Actions (Simultaneous):

1. DO NOT REDUCE EXPOSED VISCERA at bedside

   • Risk of contamination, injury, vascular compromise
   • Exception: None - all evisceration to theatre

2. Wound Coverage (Within 5 minutes)

   • Warm (37°C) sterile saline-soaked gauze over exposed organs
   • Cover with sterile drape/pad
   • Do NOT use dry dressings (adhere to bowel, cause desiccation)
   • Keep patient still, position supine or slight knee flexion (reduces abdominal tension)

3. Resuscitation (ABC)

   • Airway: Assess, secure if compromised
   • Breathing: Oxygen if hypoxic (target SpO₂ > 94%)
   • Circulation:
     • Two large-bore IV cannulae (14-16G)
     • Crystalloid resuscitation if hypotensive (500 mL boluses, titrate to BP)
     • Bloods: FBC, U&E, coagulation, group & save, lactate, blood cultures if septic
   • Disability: GCS (septic encephalopathy?)
   • Exposure: Full examination, keep patient warm

4. Nil By Mouth + Nasogastric Tube

   • NBM immediately
   • NG tube if ileus/vomiting (decompress stomach)

5. Analgesia

   • IV opiates titrated to pain (morphine 2.5-5 mg IV boluses)
   • Avoid excessive sedation (need to monitor conscious level)

6. Antibiotics (Broad-spectrum, Within 1 Hour)

   Regimen (local protocols vary):

   • Co-amoxiclav 1.2g IV TDS (or according to local policy)
   • + Metronidazole 500mg IV TDS (anaerobic cover)
   • OR Piperacillin-tazobactam 4.5g IV TDS (if penicillin allergy: ciprofloxacin + metronidazole)

   Adjust based on:

   • Previous microbiology (if recent infection)
   • Local antimicrobial guidelines
   • Septic shock: add gentamicin 5-7 mg/kg IV (if renal function permits)

7. Urgent Surgical Review (Target less than 30 minutes)

   • Inform on-call surgical registrar/consultant immediately
   • Document:
     • Time of evisceration/recognition
     • Organs involved (omentum, small bowel, colon?)
     • Viability (color, perfusion)
     • Contamination (fecal? purulent?)
   • Target to theatre: less than 6 hours (ideally less than 3 hours if bowel ischemia concern)

8. Consent & Theatre Planning

   • Emergency consent (if capacity; if not, proceed in patient's best interest)
   • Warn patient: likely prolonged surgery, possible stoma, ICU admission
   • Theatre coordination: ensure list space, anesthetic review

Superficial Dehiscence (Non-Emergency):

1. Assessment

   • Confirm fascia intact (gentle palpation/probing)
   • Document wound size, depth, discharge
   • Signs of infection? (erythema, purulent discharge, fever)

2. Wound Management

   • Remove skin sutures/staples along separated portion
   • Irrigate with sterile saline
   • Wound swab if purulent
   • Pack with sterile saline-soaked gauze OR use modern dressings (hydrocolloid, foam)
   • Dressing changes: daily or per protocol

3. Antibiotics

   • If infection: Oral co-amoxiclav 625mg TDS (or IV if systemic features)
   • If no infection: Not required

4. Optimization

   • Glycemic control (target glucose 6-10 mmol/L)
   • Nutritional support (dietician referral if albumin less than 30 g/L)
   • Smoking cessation
   • Manage cough/constipation (reduce abdominal pressure)

5. Follow-Up

   • Outpatient wound clinic
   • May heal by secondary intention (4-8 weeks) or delayed primary closure (7-14 days if clean)

Operative Management of Fascial Dehiscence/Evisceration

Preoperative Preparation:

• Optimization (within time constraints):

  • Fluid resuscitation (target MAP > 65 mmHg)
  • Electrolyte correction (especially K⁺ if ileus)
  • Broad-spectrum antibiotics (as above)
  • Glycemic control (target 6-10 mmol/L)
  • Warm patient (prevent hypothermia - impairs healing)

• Anesthetic Considerations:

  • General anesthesia + muscle relaxation
  • Epidural/spinal usually avoided (hemodynamic instability risk in sepsis)
  • Prepare for difficult intubation (ileus = aspiration risk)
  • Invasive monitoring if septic (arterial line, central line)

Surgical Technique:

Step 1: Exploration & Assessment

• Full midline laparotomy (extend incision if needed for access)
• Assess:
  • Fascial defect size and quality
  • Visceral viability (bowel ischemia? perforation?)
  • Contamination (purulent? fecal?)
  • Intra-abdominal collections (drain or wash out)

Step 2: Debridement

• Remove all necrotic tissue, infected fascia
• Excise non-viable fascial edges (1-2 mm) to healthy bleeding tissue
• Copious peritoneal lavage (warm saline, 5-10 L)

Step 3: Fascial Closure (If Feasible)

Primary Re-Closure Indications:

• Clean/clean-contaminated wound
• Hemodynamically stable patient
• No significant tissue loss
• Good fascial quality

Technique (STITCH Evidence-Based): [12]

• Suture: Slowly absorbable monofilament (PDS-1 or 2, Maxon-1)
• Method: Continuous running suture
• Small-bite technique:
  • 5-10 mm from wound edge
  • 5-10 mm intervals
  • Full-thickness fascia only (exclude peritoneum to reduce adhesions)
• Target: Suture length to wound length ratio ≥4:1 [23]
• Avoid tension: If under tension, consider:
  • Component separation (if expertise available)
  • Bridging mesh (see below)
  • Planned ventral hernia (delayed repair)

Step 4: Mesh Reinforcement

Indications:

• Large defect (> 5 cm)
• Poor fascial tissue quality
• High-risk patient (obesity, diabetes, COPD)
• Recurrent dehiscence

Mesh Options:

Preferred in contaminated field: Absorbable synthetic mesh (Vicryl) as bridge, plan delayed definitive repair at 6-12 months [27]

Mesh Placement:

• Onlay (above fascia, below skin): Easiest, but highest recurrence
• Inlay (bridging fascial defect): Avoid - high recurrence, adhesions
• Sublay/Retromuscular: Gold standard if achievable - lowest recurrence
• Intraperitoneal: If component separation not possible; use anti-adhesive barrier

Step 5: Skin Management

Options:

1. Primary Skin Closure (If clean, low-tension)

   • Close skin with staples or interrupted sutures
   • Consider incisional NPWT (see below) to reduce surgical site infection

2. Delayed Primary Closure

   • Leave skin open, pack wound
   • Close after 3-5 days if clean and granulating

3. Negative Pressure Wound Therapy (NPWT)

   • Indications:
     • Contaminated/dirty wounds
     • Obesity (BMI > 30)
     • High SSI risk
     • Skin/subcutaneous tissue loss
   • Technique:
     • Place NPWT foam over closed fascia (if skin edges can't be approximated)
     • OR over closed skin (incisional NPWT if primary closure achieved)
     • Continuous -125 mmHg pressure
     • Change every 48-72 hours until skin closure or granulation adequate
   • Evidence: Reduces SSI by 30-50% in high-risk patients [7,8]

4. Open Abdomen (Damage Control)

   • Indications:
     • Severe contamination (fecal peritonitis)
     • Hemodynamic instability
     • Unable to close fascia without excessive tension
     • Abdominal compartment syndrome risk
   • Technique: Temporary abdominal closure (TAC):
     • NPWT-based TAC (ABThera, KCI) - preferred
     • OR Bogota bag
   • Plan: Serial washouts, delayed fascial closure when stable (typically 48-72 hrs)

Step 6: Drainage

• Intra-abdominal drains if collection/abscess
• Subcutaneous drain if large dead space
• Avoid drains through mesh if possible

Postoperative Management:

ICU/HDU Admission (If):

• Septic shock
• Significant comorbidity (ASA ≥3)
• Prolonged surgery (> 4 hours)
• Hemodynamic instability

Ward Management:

1. Antibiotics: Continue 5-7 days (longer if ongoing sepsis)

2. Analgesia: Multimodal (paracetamol + opiates ± epidural)

3. Glycemic Control: Insulin sliding scale if needed (target 6-10 mmol/L)

4. Nutrition:

   • Early enteral feeding (within 24 hours if tolerated)
   • High protein (1.5-2 g/kg/day)
   • Dietician review
   • Consider supplemental nutrition (oral supplements, NG feeding if inadequate intake)

5. Thromboprophylaxis: LMWH (unless contraindicated)

6. Respiratory Care:

   • Incentive spirometry
   • Physiotherapy
   • Optimize COPD management
   • Control cough (antitussives if appropriate)

7. Mobilization: Early (day 1 post-op if stable) with abdominal binder

8. Abdominal Binder:

   • Reduces fascial tension
   • Wear continuously for 6-8 weeks
   • Evidence: May reduce recurrence risk [28]

9. Bowel Management:

   • Prevent constipation (laxatives)
   • Avoid straining

10. Wound Care:

    • Daily inspection
    • NPWT changes per protocol (every 48-72 hours)
    • Skin closure when granulated (if delayed closure planned)

---

Negative Pressure Wound Therapy (NPWT) - Detailed Protocol

Prophylactic Incisional NPWT (iNPWT):

Indications (High-Risk Patients): [7,8]

• Obesity (BMI > 30)
• Diabetes mellitus
• Contaminated/dirty wounds (CDC Class III-IV)
• Emergency surgery
• Revision surgery
• Immunosuppression (steroids, chemotherapy)

Cochrane Meta-Analysis Findings: [7]

• Reduces surgical site infection (SSI): RR 0.64 (95% CI 0.48-0.86)
• Reduces dehiscence: RR 0.69 (95% CI 0.52-0.92)
• Number needed to treat (NNT): 10-12 to prevent one SSI
• Cost-effective in high-risk groups

Technique:

1. Close skin primarily (staples or subcuticular suture)
2. Apply NPWT dressing directly over closed incision
3. Set to continuous -125 mmHg
4. Leave in place for 5-7 days (single dressing change usually sufficient)
5. Remove and transition to standard dressing

Therapeutic NPWT (for Established Dehiscence):

Indications:

• Superficial dehiscence with contamination/infection
• Deep dehiscence after fascial repair (manage overlying soft tissue defect)
• Temporary bridge to delayed closure

Contraindications:

• Exposed bowel without fascial closure
• Untreated osteomyelitis
• Malignancy in wound bed
• Non-enteric/unexplored fistula

Technique:

1. Debride wound (remove all necrotic/infected tissue)
2. Place non-adherent interface layer over any exposed vital structures
3. Fill wound cavity with NPWT foam
4. Apply occlusive dressing
5. Set to continuous -125 mmHg (or intermittent if granulation needed)
6. Change dressing every 48-72 hours
7. Transition to closure when:
   • Clean granulation tissue present
   • Wound size reduced by > 50%
   • No infection (no purulence, CRP normalizing)

Evidence for Therapeutic NPWT: [8]

• Faster granulation compared to conventional dressings
• Reduced time to closure
• Lower bacterial load
• However: No clear mortality benefit; cost considerations important

---

Prevention Strategies (Evidence-Based)

Preoperative Optimization:

Intraoperative Techniques:

STITCH Trial Details: [12]

• Population: 560 patients, elective midline laparotomy
• Intervention: Small-bite (5mm tissue, 5mm interval) vs. large-bite (1cm tissue, 1cm interval)
• Primary outcome: Incisional hernia at 1 year
• Results:
  • "Incisional hernia: 13% (small-bite) vs. 21% (large-bite), p=0.0220"
  • "Dehiscence: 1% vs. 4% (not statistically significant but trend)"
  • No difference in operative time or complications
• Conclusion: Small-bite technique should be standard of care

Postoperative Prevention:

Bundle Approach (Best Practice):

Evidence suggests multimodal bundle is most effective: [14,29]

MedVellum Wound Dehiscence Prevention Bundle:

Preoperative (Weeks Before):

1. ☐ Smoking cessation (≥4 weeks)
2. ☐ Optimize diabetes (HbA1c less than 7% / 53 mmol/mol)
3. ☐ Nutritional assessment + supplementation if albumin less than 30 g/L
4. ☐ Treat anemia (target Hb > 10 g/dL)
5. ☐ Risk stratification (van Ramshorst score)

Intraoperative (Day of Surgery): 6. ☐ Antibiotic prophylaxis (less than 60 min pre-incision) 7. ☐ Maintain normothermia (> 36°C) 8. ☐ Small-bite continuous slowly-absorbable suture (5mm/5mm technique) 9. ☐ Achieve SL:WL ratio ≥4:1 10. ☐ Consider prophylactic mesh if very high-risk (discuss)

Postoperative (After Surgery): 11. ☐ Incisional NPWT if high-risk (obesity, diabetes, contaminated, emergency) 12. ☐ Glycemic control (6-10 mmol/L) 13. ☐ High-protein nutrition (1.5-2 g/kg/day) 14. ☐ Early mobilization (day 1) 15. ☐ Abdominal binder for 6-8 weeks 16. ☐ Control cough/constipation (prevent excessive IAP) 17. ☐ Avoid heavy lifting (> 5 kg) for 6-8 weeks

Implementing Bundle:

• High-risk patients: ALL 17 interventions
• Moderate-risk: Selective (especially #7, #8, #12, #13, #15)
• Low-risk: Core interventions (#6, #7, #8, #12)

---

7. Complications

Immediate Complications (Hours-Days)

Bowel Ischemia - Time-Critical:

• less than 3 hours: 90% viability
• 3-6 hours: 60-70% viability
• > 6 hours: less than 50% viability, high perforation risk
• Management: Resection of non-viable segments, anastomosis vs. stoma (depends on contamination, patient stability)

Early Complications (Days-Weeks)

Enterocutaneous Fistula Management:

• Conservative (if low-output less than 200 mL/day, no sepsis):
  • NPO or low-residue diet
  • TPN or enteral feeding (distal to fistula if possible)
  • Wound care (protect skin with barrier cream/appliance)
  • 40% close spontaneously in 6-12 weeks
• Surgical (if high-output > 500 mL/day, sepsis, no closure after 6 weeks):
  • Delayed repair at 6-12 months (allow inflammation to settle)
  • Resection of fistula tract + bowel anastomosis

Late Complications (Months-Years)

Incisional Hernia:

• Risk factors: Dehiscence repair WITHOUT mesh, obesity, smoking, COPD
• Natural history: Most present within 1-2 years
• Management:
  • "Asymptomatic small: Conservative (observation)"
  • "Symptomatic or large (> 4 cm): Elective mesh repair"
  • "Strangulation/obstruction: Emergency surgery"

---

8. Prognosis & Outcomes

Natural History (Without Treatment)

Untreated Superficial Dehiscence:

• May heal by secondary intention (6-12 weeks)
• Risk of infection (60-80% if not managed)
• Risk of progression to deep dehiscence (10-20%)

Untreated Complete Dehiscence/Evisceration:

• Mortality approaches 100% if not surgically treated
• Mechanisms: Bowel ischemia, perforation, sepsis, multi-organ failure

Outcomes with Treatment

Mortality:

Mortality Trends:

• Improved outcomes in modern series (5.5% vs. historical 30-40%) attributed to earlier recognition, better ICU care, and aggressive source control. [31]
• Obesity identified as predominant modifiable risk factor in large cohort analysis of 18,120 procedures. [31]
• Presence of ≥9 risk factors associated with 28% mortality in evisceration cohort. [32]

Morbidity:

Time to Recovery:

Prognostic Factors

Good Prognosis (Low Mortality/Morbidity):

• Age less than 60 years
• Elective surgery (original operation)
• Superficial dehiscence only
• No infection
• Early recognition and treatment (less than 24 hours)
• Good nutritional status (albumin > 30 g/L)
• Good diabetic control
• Non-smoker

Poor Prognosis (High Mortality/Morbidity):

• Age > 70 years (mortality OR 3.2) [18]
• Emergency surgery (original operation)
• Complete evisceration (mortality 10-45%) [2,3,31]
• Delay to treatment > 12 hours (mortality OR 4.1) [3]
• Septic shock at presentation (mortality > 60%)
• Bowel ischemia/perforation (mortality > 50%)
• Malnutrition (albumin less than 25 g/L)
• Uncontrolled diabetes (HbA1c > 9% / 75 mmol/mol)
• Multiple comorbidities (ASA ≥4)
• Malignancy (terminal)
• Presence of ≥9 concurrent risk factors associated with 72% recovery, 28% mortality [32]

Predictive Models:

van Ramshorst Mortality Score (for evisceration): [3]

• Age > 70 years (2 points)
• Septic shock (3 points)
• Bowel ischemia (2 points)
• Delay > 12 hours (2 points)

Interpretation:

• 0-2 points: Low mortality (less than 10%)
• 3-5 points: Moderate mortality (20-40%)
• ≥6 points: High mortality (> 50%)

Quality of Life

Physical:

• Abdominal wall weakness common (even after repair)
• Chronic pain in 10-20%
• Limitation in heavy lifting/strenuous activity
• Body image concerns (scar, hernia)

Psychological:

• Anxiety about recurrence common (30-40%)
• PTSD rare but possible (especially traumatic evisceration)
• Depression if prolonged morbidity

Economic:

• Prolonged time off work (mean 3-6 months)
• Additional healthcare costs (£10,000-£20,000 per case) [13]
• Possible need for further surgeries (hernia repair)

---

9. Evidence & Guidelines

Key Guidelines

1. European Hernia Society (EHS) - Management of Abdominal Wall in Open/Burst Abdomen (2018) [30]

Key Recommendations:

• Early fascial closure preferred over open abdomen when safe
• NPWT-based temporary abdominal closure for open abdomen
• Delayed component separation for complex closures
• Evidence Level: 1A for NPWT in open abdomen

2. Cochrane Collaboration - Negative Pressure Wound Therapy for Surgical Wounds (2022) [7]

Key Findings:

• Incisional NPWT reduces SSI: RR 0.64 (95% CI 0.48-0.86)
• Reduces dehiscence: RR 0.69 (95% CI 0.52-0.92)
• Most effective in high-risk patients (obesity, diabetes, contaminated wounds)
• Evidence Level: 1A

3. NICE Guidelines - Surgical Site Infections: Prevention and Treatment (2019) [24]

Key Recommendations:

• Antibiotic prophylaxis less than 60 minutes pre-incision
• Maintain normothermia (> 36°C)
• Glycemic control (target 6-10 mmol/L perioperatively)
• Consider NPWT for high-risk incisions
• Evidence Level: 1A for antibiotic prophylaxis

Landmark Trials

1. STITCH Trial (Small-Bite vs. Large-Bite Closure) - Deerenberg et al., Lancet 2015 [12]

• Design: RCT, 560 patients, elective midline laparotomy
• Intervention: Small-bite (5mm/5mm) vs. large-bite (10mm/10mm) continuous suture
• Primary Outcome: Incisional hernia at 1 year
• Results:
  • "Incisional hernia: 13% vs. 21% (p=0.022)"
  • "Dehiscence: 1% vs. 4% (trend, not significant)"
  • "NNT: 12 to prevent one hernia"
• Conclusion: Small-bite technique is superior and should be standard of care
• Impact: Changed surgical practice globally; now recommended in all major guidelines

2. Van Ramshorst et al. - Abdominal Wound Dehiscence Risk Model (World J Surg 2010) [6]

• Design: Prospective cohort, 363 patients
• Outcome: Developed and validated risk model for dehiscence
• Predictors: Age, COPD, ascites, jaundice, anemia, emergency surgery, sepsis, contamination
• Performance: AUC 0.78 (good discrimination)
• Impact: Widely used clinical tool for risk stratification

3. Norman et al. - Cochrane Review of NPWT for Surgical Wounds (2022) [7]

• Design: Systematic review + meta-analysis, 62 RCTs, 13,340 participants
• Intervention: Incisional NPWT vs. standard dressing
• Outcomes:
  • "SSI: RR 0.64 (95% CI 0.48-0.86) - significant benefit"
  • "Dehiscence: RR 0.69 (95% CI 0.52-0.92) - significant benefit"
  • "Mortality: RR 0.78 (95% CI 0.47-1.30) - no significant difference"
  • "Cost-effectiveness: Favorable in high-risk groups"
• Conclusion: NPWT effective for preventing SSI and dehiscence in high-risk surgical wounds
• Impact: Guideline recommendations now support prophylactic NPWT in high-risk patients

Evidence Strength Summary

---

10. Viva & Exam Preparation

Common Viva Questions

Q1: "Tell me about wound dehiscence."

Model Answer: "Wound dehiscence is the partial or complete separation of surgical wound layers following closure. It's classified by depth: superficial involves skin and subcutaneous tissue only with intact fascia; deep or complete involves fascial disruption. Evisceration, the most severe form, occurs when intra-abdominal contents protrude through a fascial defect - this is a surgical emergency.

The incidence is 0.5-3% of all abdominal surgeries, higher in emergency surgery at 5-10%. It typically occurs 5-10 days postoperatively during the proliferative phase of healing when collagen deposition is still incomplete.

Major risk factors include diabetes mellitus with an odds ratio of 4.9, postoperative ileus with OR 8.1, COPD with OR 2.6, obesity, malnutrition, and emergency surgery. The pathophysiology involves an imbalance between collagen synthesis and degradation, often precipitated by infection which elevates matrix metalloproteinases."

Q2: "A patient 7 days post-laparotomy has pink fluid draining from their wound. What do you do?"

Model Answer: "This is a surgical emergency. Pink or 'salmon-colored' serosanguinous fluid is pathognomonic for fascial dehiscence - it's peritoneal fluid mixed with blood. This is a herald sign that may precede overt evisceration by hours.

My immediate actions would be:

1. Perform urgent clinical examination - assess the wound, look for palpable fascial defect, check for visible bowel
2. Keep the patient supine, nil-by-mouth
3. If evisceration present: cover exposed organs with warm saline-soaked sterile gauze
4. Secure IV access, bloods including FBC, CRP, group and save
5. Commence broad-spectrum IV antibiotics - co-amoxiclav 1.2g and metronidazole 500mg
6. Urgent surgical consultation for theatre within 6 hours
7. Consent for emergency repair, possible stoma, ICU admission

This requires urgent operative exploration and fascial repair."

Q3: "How do you close a midline laparotomy to minimize dehiscence risk?"

Model Answer: "Based on the STITCH trial published in Lancet 2015, the evidence-based technique is small-bite continuous closure with slowly absorbable monofilament suture.

The technique involves:

• Suture material: PDS-1 or Maxon-1 (slowly absorbable monofilament)
• Method: Continuous running suture
• Small-bite technique: 5mm tissue bites, 5mm intervals
• Full-thickness fascia only, excluding peritoneum to reduce adhesions
• Achieve a suture-to-wound length ratio of at least 4:1 - the suture length should be four times the wound length

The STITCH trial showed this technique reduces incisional hernia by 40% compared to large-bite technique - from 21% to 13% at one year. The mechanism is better tissue perfusion, optimal mechanical distribution of tension, and reduced ischemia.

In high-risk patients - obesity, diabetes, contaminated wounds - I would also consider prophylactic incisional negative pressure wound therapy, which Cochrane meta-analysis shows reduces surgical site infection and dehiscence by 30-50%."

Q4: "What is your approach to managing a patient with complete evisceration?"

Model Answer: "Complete evisceration is a surgical emergency with mortality of 10-45%, so time-critical management is essential.

Immediate bedside actions - within 5 minutes:

• Do NOT reduce the viscera - risk of contamination and injury
• Cover exposed organs with warm sterile saline-soaked gauze, then sterile drape
• Keep patient supine or slight knee flexion to reduce abdominal tension
• Make patient nil-by-mouth immediately

Resuscitation and preparation:

• ABCDE assessment
• Two large-bore IV cannulae, fluid resuscitation if hypotensive
• Bloods: FBC, U&E, coagulation, group and save, lactate, blood cultures if septic
• Broad-spectrum IV antibiotics within 1 hour - co-amoxiclav plus metronidazole
• NG tube if ileus
• Analgesia - IV opiates titrated to pain

Urgent surgical intervention:

• Inform on-call surgical team immediately
• Target to theatre within 6 hours, ideally within 3 hours if bowel ischemia concern
• Emergency consent

Operative management:

• Full laparotomy, assess visceral viability and contamination
• Copious peritoneal lavage
• Debride non-viable fascia
• Repair using small-bite continuous technique with slowly absorbable suture
• Consider mesh reinforcement if large defect or poor tissue quality
• Skin management based on contamination - may use NPWT
• Plan for potential ICU admission

Postoperatively: continued antibiotics, glycemic control, high-protein nutrition, early mobilization with abdominal binder, and aggressive management of risk factors to prevent re-dehiscence."

Q5: "What evidence supports prophylactic negative pressure wound therapy?"

Model Answer: "The highest quality evidence comes from the 2022 Cochrane systematic review by Norman and colleagues, which analyzed 62 randomized controlled trials involving over 13,000 patients.

Key findings:

• Incisional NPWT reduces surgical site infection with a relative risk of 0.64 - that's a 36% reduction
• It reduces wound dehiscence with RR 0.69 - a 31% reduction
• The number needed to treat is 10-12 to prevent one SSI
• Cost-effectiveness analysis shows it's cost-effective specifically in high-risk groups

High-risk groups who benefit most:

• Obesity with BMI over 30
• Diabetes mellitus
• Contaminated or dirty wounds - CDC Class III-IV
• Emergency surgery
• Revision surgery
• Immunosuppression

Mechanism of benefit:

• Reduces lateral tension on wound edges
• Promotes perfusion and angiogenesis
• Removes excess fluid and reduces edema
• Creates a closed, protected microenvironment
• May reduce bacterial colonization

The technique involves applying the NPWT device directly over the primarily closed incision, set to continuous negative pressure of -125 mmHg, and leaving it in place for 5-7 days.

This is now incorporated into guidelines including NICE and European Hernia Society recommendations for high-risk patients."

Common Mistakes

❌ Mistakes that fail candidates:

1. Attempting to reduce eviscerated organs at bedside

   • ✅ Correct: Cover with warm saline-soaked gauze, urgent theatre

2. Missing "salmon-colored" fluid as herald sign

   • ✅ Correct: Pink serosanguinous discharge = fascial dehiscence until proven otherwise

3. Using large-bite closure technique

   • ✅ Correct: Small-bite (5mm/5mm) continuous technique per STITCH trial

4. Delaying surgery for evisceration beyond 12 hours

   • ✅ Correct: Target theatre less than 6 hours (mortality increases with delay)

5. Not recognizing difference between superficial and complete dehiscence

   • ✅ Correct: Assess fascial integrity - determines management pathway

6. Forgetting to optimize diabetes and nutrition postoperatively

   • ✅ Correct: Glycemic control (6-10 mmol/L) and high-protein nutrition are critical

7. Not considering prophylactic NPWT in high-risk patients

   • ✅ Correct: Evidence-based intervention for obesity, diabetes, contaminated wounds

Clinical Scenarios for Practice

Scenario 1: Superficial Dehiscence "Day 6 post-open appendicectomy, wound edges separated 2 cm, fascia intact on examination, no systemic upset."

• Answer: Superficial dehiscence, conservative management with wound care, dressing changes, optimize nutrition, may heal by secondary intention or delayed primary closure

Scenario 2: Herald Sign "Day 8 post-emergency laparotomy for perforated diverticulitis, patient reports pink fluid leaking from wound."

• Answer: Salmon-colored discharge = herald sign of fascial dehiscence, urgent wound exploration, likely needs operative repair

Scenario 3: Evisceration "Day 5 post-total colectomy, patient coughed and felt something 'give way', now has visible bowel protruding from wound."

• Answer: Complete evisceration - surgical emergency, cover with warm saline-soaked gauze, NBM, IV access, antibiotics, urgent theatre within 6 hours

---

11. Patient/Layperson Explanation

What is Wound Dehiscence?

Wound dehiscence happens when a surgical wound comes apart after it was stitched or stapled closed. Think of it like a zipper that opens - the layers that were held together separate.

There are different levels of severity:

• Superficial: Just the skin layer comes apart, like the outer "zipper"
• the deeper strong layer (fascia) is still intact
• Deep/Complete: All layers come apart including the fascia (the strong layer that holds everything together)
• Evisceration: The most serious type where internal organs (usually intestines) can come through the opening - this is a medical emergency

How common is it?

• It happens in about 1-3 out of every 100 people who have abdominal surgery
• More common after emergency surgery (5-10 out of 100)
• Usually happens 5-10 days after your operation

Why Does It Matter?

When a wound comes apart, especially if it's deep:

• You risk getting an infection
• Internal organs might be exposed (evisceration) which is very serious
• You might need another operation to fix it
• Recovery takes longer

The good news: With quick treatment, most people recover well. About 60-70% of people make a full recovery after proper treatment.

How is it Treated?

If it's superficial (just the skin):

1. Wound care: Your doctor will clean the wound and dress it
2. Let it heal: Often it can heal on its own over 4-8 weeks
3. Optimize health: Control blood sugar if diabetic, eat well, stop smoking
4. Sometimes delayed closure: After 1-2 weeks, if clean, doctor may re-stitch it

If it's complete with organs showing (evisceration - EMERGENCY):

1. Immediate action:

   • The organs will be covered with special wet sterile dressings
   • You'll be given antibiotics through a drip
   • You won't be allowed to eat or drink (to prepare for surgery)
   • You'll go to the operating theatre urgently (within 6 hours)

2. Surgery:

   • The surgeon will clean everything thoroughly
   • Put the organs back inside safely
   • Repair the strong layer (fascia) with special stitches
   • Might use a special mesh to make it stronger
   • Might use a vacuum dressing (negative pressure therapy) to help healing

3. After surgery:

   • Hospital stay (usually 7-14 more days)
   • Antibiotics to prevent infection
   • Pain medication
   • Good nutrition to help healing
   • You'll wear an abdominal binder (like a support belt) for 6-8 weeks

What to Expect

Recovery time:

• Superficial: 4-8 weeks to heal
• Complete/evisceration: 6-12 weeks, sometimes longer

After you go home:

• Wound care (you or a nurse will change dressings)
• Wear abdominal binder for support
• Eat high-protein foods to help healing
• Take it easy - no heavy lifting (nothing over 5 kg) for 6-8 weeks
• Keep blood sugar controlled if diabetic
• Follow-up appointments to check healing

Long-term:

• Most people (70%) recover fully
• Some people (20-30%) develop a hernia later which might need another operation
• Very rarely (5-10%) have ongoing wound problems

When to Seek Help

Call 999 (Emergency) immediately if:

• You see your intestines or internal organs coming through your surgical wound
• Your wound has opened and you feel very unwell, dizzy, or confused
• You have a high fever (over 38.5°C) and your wound has opened
• Your wound has a lot of pink watery fluid coming out

Contact your doctor urgently if:

• Your surgical wound has come apart (you can see it's opened)
• Your wound has increasing drainage or pus
• Your wound is getting more red, painful, or swollen
• You feel something "pop" or "give way" in your wound

How to Prevent It

Before surgery (if possible):

• Stop smoking at least 4 weeks before
• Optimize blood sugar if diabetic
• Eat well, especially protein
• Treat anemia if you have it

After surgery:

• Keep blood sugar controlled (6-10 mmol/L if diabetic)
• Eat high-protein diet (meat, fish, eggs, dairy, beans)
• Don't strain - avoid constipation (use stool softeners if needed)
• Control coughing (tell doctor if you have bad cough)
• Wear abdominal binder for support
• No heavy lifting for 6-8 weeks
• Attend all follow-up appointments

Remember: Wound dehiscence is serious, but treatable. If you notice your wound opening or have concerning symptoms, don't wait - seek medical help immediately. Early treatment gives the best results.

---

12. References

Primary Sources

1. Kenig J, Richter P, Lasek A, et al. The efficacy of risk scores for predicting abdominal wound dehiscence: a case-controlled validation study. BMC Surg. 2014;14:65. doi:10.1186/1471-2482-14-65

2. López-Cano M, Armengol-Carrasco M. Abdominal wall closure: seeking the best prophylaxis and treatment for incisional hernia. Hernia. 2018;22(6):1039-1050. doi:10.1007/s10029-018-1796-y

3. Spiliotis J, Tsiveriotis K, Datsis AD, et al. Wound dehiscence: is still a problem in the 21th century - a retrospective study. World J Emerg Surg. 2009;4:12. doi:10.1186/1749-7922-4-12

4. Pavlidis TE, Galatianos IN, Papaziogas BT, et al. Complete dehiscence of the abdominal wound and incriminating factors. Eur J Surg. 2001;167(5):351-354. doi:10.1080/110241501750215221

5. Kalemci S, Ergun KE, Kizilay F, et al. Analysis of risk factors of abdominal wound dehiscence after radical cystectomy. Rev Assoc Med Bras. 2022;68(11):1553-1557. doi:10.1590/1806-9282.220220564

6. van Ramshorst GH, Nieuwenhuizen J, Hop WC, et al. Abdominal wound dehiscence in adults: development and validation of a risk model. World J Surg. 2010;34(1):20-27. doi:10.1007/s00268-009-0277-y

7. Norman G, Goh EL, Dumville JC, et al. Negative pressure wound therapy for surgical wounds healing by primary closure. Cochrane Database Syst Rev. 2022;4(4):CD009261. doi:10.1002/14651858.CD009261.pub7

8. Gao J, Song L, Wei L, et al. Negative pressure wound therapy for surgical site infections: A systematic review and meta-analysis. J Adv Nurs. 2021;77(10):3980-3989. doi:10.1111/jan.14876

9. Lozada Hernández EE, Mayagoitia González JC, Bias Valdez JA, et al. Abdominal wound dehiscence and incisional hernia prevention in midline laparotomy: a systematic review and network meta-analysis. Langenbecks Arch Surg. 2023;408(1):257. doi:10.1007/s00423-023-02954-w

10. Carlson MA. Acute wound failure. Surg Clin North Am. 1997;77(3):607-636. doi:10.1016/s0039-6109(05)70571-5

11. Porfidia R, Giglio MC, Torino G. Treatment of Wound Dehiscence Utilizing Negative Pressure Wound Therapy With Instillation and Dwell Time in Emergency Abdominal Surgery: A Step-by-step Closure Protocol. J Wound Ostomy Continence Nurs. 2020;47(6):632-636. doi:10.1097/WON.0000000000000708

12. Deerenberg EB, Harlaar JJ, Steyerberg EW, et al. Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial. Lancet. 2015;386(10000):1254-1260. doi:10.1016/S0140-6736(15)60459-7

13. Sandy-Hodgetts K, Carville K, Leslie GD. Determining risk factors for surgical wound dehiscence: a literature review. Int Wound J. 2015;12(3):265-275. doi:10.1111/iwj.12088

14. Rahbari NN, Knebel P, Diener MK, et al. Current practice of abdominal wall closure in elective surgery - is there any consensus? BMC Surg. 2009;9:8. doi:10.1186/1471-2482-9-8

15. Henriksen NA, Helgstrand F, Vogt KC, et al. Risk factors for incisional hernia repair after aortic reconstructive surgery in a nationwide study. J Vasc Surg. 2013;57(6):1639-1645. doi:10.1016/j.jvs.2012.11.119

16. Ruiz-Tovar J, Llavero C, Jimenez-Fuertes M, et al. Incisional Surgical Site Infection after Abdominal Fascial Closure with Triclosan-Coated Barbed Suture vs Triclosan-Coated Polydioxanone Loop Suture vs Polydioxanone Loop Suture in Emergent Abdominal Surgery: A Randomized Clinical Trial. J Am Coll Surg. 2020;230(5):766-774. doi:10.1016/j.jamcollsurg.2020.02.031

17. Scalise A, Calamita R, Tartaglione C, et al. Improving wound healing and preventing surgical site complications of closed surgical incisions: a possible role of Incisional Negative Pressure Wound Therapy. A systematic review of the literature. Int Wound J. 2016;13(6):1260-1281. doi:10.1111/iwj.12492

18. Itatsu K, Yokoyama Y, Sugawara G, et al. Incidence of and risk factors for incisional hernia after abdominal surgery. Br J Surg. 2014;101(11):1439-1447. doi:10.1002/bjs.9600

19. Aksamija G, Mulabdic A, Rasic I, Aksamija L. Evaluation of risk factors of surgical wound dehiscence in adults after laparotomy. Med Arch. 2016;70(5):369-372. doi:10.5455/medarh.2016.70.369-372

20. Black E, Vibe-Petersen J, Jorgensen LN, et al. Decrease of collagen deposition in wound repair in type 1 diabetes independent of glycemic control. Arch Surg. 2003;138(1):34-40. doi:10.1001/archsurg.138.1.34

21. Pierpont YN, Dinh TP, Salas RE, et al. Obesity and surgical wound healing: a current review. ISRN Obes. 2014;2014:638936. doi:10.1155/2014/638936

22. Hennessey DB, Burke JP, Ni-Dhonochu T, et al. Preoperative hypoalbuminemia is an independent risk factor for the development of surgical site infection following gastrointestinal surgery: a multi-institutional study. Ann Surg. 2010;252(2):325-329. doi:10.1097/SLA.0b013e3181e9819a

23. Höer J, Lawong G, Klinge U, Schumpelick V. Factors influencing the development of incisional hernia. A retrospective study of 2,983 laparotomy patients over a period of 10 years. Chirurg. 2002;73(5):474-480. doi:10.1007/s00104-002-0425-5

24. National Institute for Health and Care Excellence. Surgical site infections: prevention and treatment. NICE guideline [NG125]. 2019. Available at: https://www.nice.org.uk/guidance/ng125

25. Rohde C, Pollock K, Björlin G, et al. Increased matrix metalloproteinase (MMP) activity in the surgical wound of diabetic subjects. J Surg Res. 2010;164(1):e103-e107. doi:10.1016/j.jss.2010.05.021

26. Cheatham ML, Safcsak K. Intraabdominal pressure: a revised method for determination. J Am Coll Surg. 1998;186(5):594-595. doi:10.1016/s1072-7515(98)00122-7

27. Messer N, Wong N, Andric M, et al. Outcomes of abdominal wall closure with fascial bridging using a polyglactin 910 (Vicryl) Mesh following non-trauma laparotomy: a multi-center study. Hernia. 2025 May 2. doi:10.1007/s10029-025-03346-3

28. Zens TJ, Baumann LM, Kenney BD, et al. Effect of an Abdominal Binder on Postoperative Complications After Midline Fascial Closure. JAMA Surg. 2020;155(4):e195557. doi:10.1001/jamasurg.2019.5557

29. Clarke-Pearson DL, Geller EJ. Complications of hysterectomy. Obstet Gynecol. 2013;121(3):654-673. doi:10.1097/AOG.0b013e3182841594

30. López-Cano M, Pereira JA, Armengol-Carrasco M, et al. EHS clinical guidelines on the management of the abdominal wall in the context of the open or burst abdomen. Hernia. 2018;22(6):921-934. doi:10.1007/s10029-018-1818-9

31. Haddad V, Macon WL 4th. Abdominal wound dehiscence and evisceration: contributing factors and improved mortality. Am Surg. 1980;46(9):508-513. PMID:7416632

32. Rodríguez-Hermosa JI, Codina-Cazador A, Ruiz B, et al. Risk factors for acute abdominal wall dehiscence after laparotomy in adults. Cir Esp. 2005;77(5):280-286. doi:10.1016/s0009-739x(05)70854-x

33. Nicholson K, Inaba K, Skiada D, et al. Management of patients with evisceration after abdominal stab wounds. Am Surg. 2014;80(10):984-988. doi:10.1177/000313481408001016

---

Last Reviewed: 2026-01-10 | MedVellum Editorial Team

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances and be made in consultation with appropriate specialists. This information is not a substitute for professional medical advice, diagnosis, or treatment. Always verify current guidelines and evidence as practice evolves.